Kabra Drugs Limited has announced a board meeting to approve the financial results for the quarter and half-year.

The company has also made public the audited financial results for the quarter and year ended March 31, 2025, through advertisements in both English and Hindi newspapers.

This disclosure ensures transparency and keeps shareholders informed about the company’s financial health and operational performance.